We invite you to join us at VITAFOODS ASIA DIGITAL WEEK
Get in touch with us and learn all about how biotrasformation processes can lead to a better living and how we can transform compounds in a living system. ...
27 January, 2021
Get in touch with us and learn all about how biotrasformation processes can lead to a better living and how we can transform compounds in a living system. ...
QuatrefloraTM is a patented and proprietary strain Saccharomyces cerevisiae CNCM I-3856 with widely described mechanisms of actions and 6 scientific publications in peer-review journal about its efficacy in maintaining proper vaginal balance....
From January 25th to 28th, Gnosis by Lesaffre participates as a Gold sponsor to NutrEvent Winter 2021 - the European event dedicated to innovations in Food, Feed, Nutrition and Health sectors....
Low K2 intake correlates with cardiovascular disease mortality before age 65 in 168 countries....
As an active player in the probiotic market , Gnosis By lesaffre is proud to be one of the 110 member companies of the IPA. Marc Philouze , General Manager of Gnosis By Lesaffre, join the IPA’s Board of directors so that allows us to...
Through this hub, current and potential new customers will be able to find us and connect with us, attend 1:1 meetings, doing business directly with us or simply learn more about our ingredients, services and expertise....
NattoPharma research partners publish important review paper clearly identifying the need for a Vitamin K2-specific RDI (Recommended Daily Intake)....
Millions of children worldwide suffer from diarrhea every year and are at risk of dehydration. Oral rehydration solution is central in the World Health Organization’s guidelines on the management of acute diarrhea in children...
LifeinU™ BSCU1 is one of the most stable probiotic, from a strain of Bacillus subtilis, a common and non-pathogenic bacterium, which may support immunity and is supported by a clinical study. The stability of LifeinU™ BSCU1 is higher compared to other historical probiotics. Where the guaranteed...
New review paper, completed as part of INTRICARE research grant, identifies vitamin K2’s crucial role in inflammation and cardiovascular health....
Study dovetails earlier research showing improved COVID-19 recovery outcomes in individuals with higher K2 status....
The leaflet describes the latest clinical study conducted on 456 IBS volunteers, presented in october during the United European Gastroenterology virtual week. In this study, ibSium® confirmed its efficacy to alleviate abdominal pain and ...
CORPORATE HEADQUARTERS
101 rue de Menin
59700 Marcq-en-Baroeul
France
We are a proud business unit of Lesaffre.
Enter your contact information below to be added to our monthly email newsletter, keeping you up-to-date with the latest information from Gnosis by Lesaffre
Get in the conversation – follow us on social media!
The information provided here is, to the best of our knowledge, true and accurate. However, our products must only be used in compliance with local laws and regulations. We cannot guarantee the freedom of use for every intended application or country. These statements may not have been evaluated by your local Food and Drug Administration. Our products are not intended to diagnose, treat, cure, or prevent any disease. A healthy, balanced and diversified diet should fulfill all nutritional needs.
©2020 Gnosis by Lesaffre | Legal Notices